The diagnostic criteria for SPS include clinical presentation, neurological examination, exclusion of other neurological disorders, electromyographic evidence of simultaneous motor unit action potentials (MUAPs) in agonist and antagonist muscles, and positive serology for anti-GAD antibodies (1–3). The gene discussed is GAD1; the disease is nervous system disorder.